Anthropometric variables | Lung cancer N = 20 | Lung cancer-COPD N = 20 |
---|---|---|
Age, years | 64 (12) | 65 (9) |
Male, N/female, N | 13/7 | 20/0 |
BMI, kg/m2 | 26 (5) | 26 (5) |
Smoking history | ||
Current: N, % | 12, 60 | 14, 70 |
Ex-smoker: N, % | 5, 25 | 6, 30 |
Never smoker: N,% | 3, 15 | 0, 0¶ |
Pack-years | 53 (25) | 57 (20) |
Lung function testing | ||
vFEV1, % pred | 92 (8) | 61 (14)¶¶¶ |
FEV1/FVC, % pred | 77 (6) | 60 (8)¶¶¶ |
DLCO, % pred | 88 (12) | 72 (21)¶¶¶ |
KCO, % pred | 88 (11) | 73 (17)¶¶¶ |
TNM staging | ||
Stage IA: N, % | 5, 25 | 5, 25 |
Stage IB: N, % | 0, 0 | 4, 20 |
Stage IIA: N, % | 1, 5 | 6, 30 |
Stage IIB: N, % | 4, 20 | 2, 10 |
Stage IIIA: N, % | 3, 15 | 3, 15 |
Stage IIIB: N, % | 4, 20 | 0, 0 |
Stage IV: N, % | 3, 15 | 0, 0 |
Histological diagnosis | ||
Squamous cell carcinoma: N, % | 6, 30 | 5, 25 |
Adenocarcinoma: N, % | 11, 55 | 14, 70 |
Others: N, % | 3, 15 | 1, 5 |
Blood parameters | ||
Total leucocytes/μL | 8.3 103 (1.9 103) | 9.2 103 (2.1 103) |
Total neutrophils/μL | 5.7 103 (2.1 103) | 6.3 103 (1.7 103) |
Total lymphocytes/μL | 1.7 103 (650) | 2.1·103 (617) |
Albumin (g/dL) | 4.4 (0.4) | 4.0 (0.5)¶¶ |
Total proteins (g/dL) | 7.4 (0.5) | 7.1 (0.6) |
Fibrinogen (mg/dL) | 485 (99) | 409 (77)¶¶ |
CRP (mg/dL) | 1.1 (1.1) | 1.7 (1.2) |
GSV (mm/h) | 20 (7.4) | 30 (16.8)¶ |
Ceruloplasmin (g/dL) | 26.2 (4.8) | 26.5 (4.8) |
Body weight loss, kg | ||
0, N, % | 18, 90 | 17, 85 |
1–4, N, % | 2, 10 | 1, 5 |
5–8, N, % | 0, 0 | 2, 10 |
9–12, N, % | 0, 0 | 0, 0 |